Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01210066 · ClinicalTrials.gov registry record · Phase 1
Pain, Opioids and Pro-Inflammatory Immune Responses
A Phase 1 study, sponsored by University of California, Los Angeles.
- Terminated
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
NCT01210066 is a Phase 1 study that was terminated before completion, run by University of California, Los Angeles. The registered enrollment target is 21 participants.
The verdict
NCT01210066, a Phase 1 study, was terminated before completion, sponsored by University of California, Los Angeles.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
Providing pain management to the patient who abuses prescription opioids presents a clinical challenge, not only due to concerns about "drug-seeking", but because they have increased sensitivity to pain, a phenomenon identified as opioid-induced hyperalgesia (OIH). In an effort to improve pain treatment, the aims of the proposed work are to evaluate the analgesic and hyperalgesic effects of opioids to acute pain in this vulnerable population, and to examine the role of opioid-induced proinflammatory changes in these responses.
Interventions
- OTHER Cold pressor test
- DRUG Fentanyl
- OTHER Fentanyl plus cold pressor test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2010-07 |
| Est. Completion | 2012-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01210066
The ClinicalTrials.gov registry entry for NCT01210066 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cold pressor test is the first listed.
NCT01210066 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01210066 about?
NCT01210066 is a clinical study titled "Pain, Opioids and Pro-Inflammatory Immune Responses". Providing pain management to the patient who abuses prescription opioids presents a clinical challenge, not only due to concerns about "drug-seeking", but because they have increased sensitivity to pain, a phenomenon identified as opioid-induced hyperalgesia (OIH). In an effort to improve pain treat...
What is the current status of trial NCT01210066?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2010-07. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01210066?
The interventions under investigation include: Cold pressor test (OTHER), Fentanyl (DRUG), Fentanyl plus cold pressor test (OTHER).
Who is sponsoring clinical trial NCT01210066?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.